Monday, 26 Jun 2017

Biologic/Novel Rx

Datesort ascending Type Title Save
06 Jan 2017 Social Despite failure in #SLE Studies, #Rituxan has wide off label use in 0.5-1.5% of lupus patients in the EU. https://t.co/NAPl3Jo70A
02 Jan 2017 Social Hospira (biosimilar division of Pfizer) began to ship Inflectra biosimilar to U.S. wholesalers on Nov. 21 & has a sales force in place
22 Dec 2016 News CHMP Recommend Baricitinib for Approval in Europe
17 Dec 2016 Social CHMP has recommended the approval of JAK inhib Baricitinib for mono or combo use in RA in EU. Trade name (Olumiant) https://t.co/9eglcVOq3Z
14 Dec 2016 Social IL-33 a biomarker for RTX response - if RA pts are RF+ or CCP+; w/ detectable serum IL-33 & High IgG levels. https://t.co/meig18rSEX
12 Dec 2016 Social 21 Pts w/ chronic mucocutaneous Candidiasis due to autosomal recessive IL-17RA deficiency starts infancy w/ Staph & Candida infx deficiency
09 Dec 2016 News Rituximab May Reduce Mortality Risk in Rheumatoid Lung Disease
08 Dec 2016 News CanVasc Recommendations for ANCA-Associated Vasculitis
07 Dec 2016 News Nonsignificant CV Risk with Actemra vs Enbrel
02 Dec 2016 News Is ABT-494 the Next JAK Inhibitor?
02 Dec 2016 Social Tofacitinib is not associated with a higher risk of malignancy. https://t.co/zInnHORI46
29 Nov 2016 Social Good, basic overview of Biosimilars. https://t.co/N0hE8xL8Ga
23 Nov 2016 Social RT @RWCSmtg: Jaknibs inhibit widely a cross a range of cytokines. https://t.co/iW2zjjefdg https://t.co/ThHnz3b1Of
22 Nov 2016 Social RT @DrPetryna: Sarilumab (IL6R) superior to Humira in MONARCH phase 3 trial. neutropenia &abn LFT > with sarilumab https://t.co/2Rwxz8hiZQ…
21 Nov 2016 News Ustekinumab Effective and Safe in Crohn's Colitis
17 Nov 2016 Social RT @DrAiLynTan: Great slide on comparing biologic therapy in #rheumatoidarthritis v #Crohns v #ulcerativecolitis via @JoseCamposMD #ACR16 h…
17 Nov 2016 Social RT @AngusWorthing: Dr Fratazzi on #biosimilars switching trials: must be 2 way (ie alternating) for interchangeability; & improve patient r…
17 Nov 2016 Social RT @CCalabreseDO: Dual cytokine inhibition with ABT-122 (targets TNFa and IL-17) for RA. check out abstract 3225. Genovese, et al. #ACR16 @…
16 Nov 2016 Social RT @rachelthuston: TCZ for clinical remission in GCA but doesn't fully suppress MR signals of vessel inflammation #ACR16 @RheumNow https://…
16 Nov 2016 Social RT @CCalabreseDO: Meaningful benefits in fatigue & HRQoL for SLE pts on long-term belimumab. Strand, et al. Abstract 3235 #ACR16 @RheumNow